|
|
|
|
|
|
|
|
|
• |
|
Biochemical and cellular assays |
|
|
|
• |
Biophysics assays for kinetics/affinity characterization |
|
|
• |
Various assay formats with capability to run both end-point and real-time kinetic analysis in high throughput format |
|
|
|
|
|
HD Biosciences' reputable in vitro pharmacology platforms, synergized with WuXi AppTec powerful chemistry platform and featured with structural biology platform from CRELUX, |
provide comprehensive solutions supporting PROTAC drug R&D. |
|
• |
|
Binary/Ternary Complex Formation Assay Platform |
|
Biochemical/Biophysics assays |
• |
|
Binary/ternary binding assays at formats on TR-FRET, AlphaScreen, Fluorescence Polarization (FP), radioactive assays, etc. |
|
• |
Biophysics approach with SPR (Biacore 8K+) and thermo shift assays |
|
SPR assay measures the kinetics of binary/ternary complex formation and provides rationale for preferred-ternary-complex-formation in PROTAC design and. |
optimization. |
|
|
|
|
Representative data for SPR Assay |
|
|
|
Cellular assays |
• |
|
Target-E3 ligase PPI assay (NanoBRET) |
|
NanoBRET cellular PPI assay evaluates target-E3 complex formation at desirable expression level and compatible with both end-point and real-time kinetic analysis |
|
• |
Target/E3 engagement assay (NanoBRET) |
|
|
• |
|
Target Ubiquitination & Degradation Assay Platform |
|
Biochemical assays |
• |
|
Target ubiquitination assay (TR-FRET, AlphaScreen) |
Cellular assays |
• |
|
Target ubiquitination assay (NanoBRET) |
• |
Target recruitment to proteasome assays (NanoBRET) |
• |
Target degradation assay (HiBiT, AlphaLISA, TR-FRET, ELISA,) |
|
HiBiT cellular assay enables monitoring of target protein degradation at |
physiological level and provides both end-point and kinetic detections |
|
|
 |
 |
|
To receive more information on HDB PROTAC service, please contact us at |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
---------------------- |
|
|
---------------------- |
|
|
|
|
|
|
|
|
|
|
|
|
|
沪公网安备 31011502003320号